Site icon OncologyTube

KY1044 Targets ICOS @kymabltd @rcasainson

Richard Sainson, PhD @rcasainson of @kymabltd answers KY1044, targets ICOS increasing cytotoxic to regulatory T cells ratio: how does this affect treatment?

Exit mobile version